Metabolic and cardiovascular effects of 13-week utreglutide treatment in individuals with obesity and MASLD: Vienna, Austria, 15 - 19 September 2025

Rajamannar Thennati; Vinod S. Burade; M. Natarajan; P. Shahi; R. Nagaraja; Bernard Thorens; Tina Vilsbøll; Richard Pratley; J Olynyk; Rohit S Loomba

doi:10.1007/s00125-025-06497-1

Metabolic and cardiovascular effects of 13-week utreglutide treatment in individuals with obesity and MASLD: Vienna, Austria, 15 - 19 September 2025

Rajamannar Thennati
, Vinod S. Burade
, M. Natarajan
, P. Shahi
, R. Nagaraja
, Bernard Thorens
, Tina Vilsbøll
, Richard Pratley
, J Olynyk
, Rohit S Loomba

Steno Diabetes Center Copenhagen

Original language	English
Article number	LBA 58
Journal	Diabetologia
Volume	68
Issue number	Suppl 1
Pages (from-to)	S676
ISSN	0012-186X
DOIs	https://doi.org/10.1007/s00125-025-06497-1
Publication status	Published - Oct 2025
Event	61th EASD Annual Meeting: EASD 2025 - Wien, Austria Duration: 15 Sept 2025 → 19 Sept 2025

Conference

Conference	61th EASD Annual Meeting: EASD 2025
Country/Territory	Austria
City	Wien
Period	15/09/2025 → 19/09/2025

Access to Document

10.1007/s00125-025-06497-1Licence: Unspecified

Cite this

Thennati, R., Burade, V. S., Natarajan, M., Shahi, P., Nagaraja, R., Thorens, B., Vilsbøll, T., Pratley, R., Olynyk, J., & Loomba, R. S. (2025). Metabolic and cardiovascular effects of 13-week utreglutide treatment in individuals with obesity and MASLD: Vienna, Austria, 15 - 19 September 2025. Diabetologia, 68(Suppl 1), S676. Article LBA 58. https://doi.org/10.1007/s00125-025-06497-1

Metabolic and cardiovascular effects of 13-week utreglutide treatment in individuals with obesity and MASLD: Vienna, Austria, 15 - 19 September 2025. / Thennati, Rajamannar; Burade, Vinod S.; Natarajan, M. et al.
In: Diabetologia, Vol. 68, No. Suppl 1, LBA 58, 10.2025, p. S676.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Thennati, R, Burade, VS, Natarajan, M, Shahi, P, Nagaraja, R, Thorens, B, Vilsbøll, T, Pratley, R, Olynyk, J & Loomba, RS 2025, 'Metabolic and cardiovascular effects of 13-week utreglutide treatment in individuals with obesity and MASLD: Vienna, Austria, 15 - 19 September 2025', Diabetologia, vol. 68, no. Suppl 1, LBA 58, pp. S676. https://doi.org/10.1007/s00125-025-06497-1

@article{ceeb15380c154d84a9894afeaa562090,

title = "Metabolic and cardiovascular effects of 13-week utreglutide treatment in individuals with obesity and MASLD: Vienna, Austria, 15 - 19 September 2025",

author = "Rajamannar Thennati and Burade, \{Vinod S.\} and M. Natarajan and P. Shahi and R. Nagaraja and Bernard Thorens and Tina Vilsb{\o}ll and Richard Pratley and J Olynyk and Loomba, \{Rohit S\}",

year = "2025",

month = oct,

doi = "10.1007/s00125-025-06497-1",

language = "English",

volume = "68",

pages = "S676",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "Suppl 1",

note = "61th EASD Annual Meeting: EASD 2025, EASD ; Conference date: 15-09-2025 Through 19-09-2025",

}

TY - ABST

T1 - Metabolic and cardiovascular effects of 13-week utreglutide treatment in individuals with obesity and MASLD

T2 - 61th EASD Annual Meeting: EASD 2025

AU - Thennati, Rajamannar

AU - Burade, Vinod S.

AU - Natarajan, M.

AU - Shahi, P.

AU - Nagaraja, R.

AU - Thorens, Bernard

AU - Vilsbøll, Tina

AU - Pratley, Richard

AU - Olynyk, J

AU - Loomba, Rohit S

PY - 2025/10

Y1 - 2025/10

U2 - 10.1007/s00125-025-06497-1

DO - 10.1007/s00125-025-06497-1

M3 - Conference abstract in journal

SN - 0012-186X

VL - 68

SP - S676

JO - Diabetologia

JF - Diabetologia

IS - Suppl 1

M1 - LBA 58

Y2 - 15 September 2025 through 19 September 2025

ER -